在两个无症状患者中偶然发现了凝血因子VII缺乏症
Nourelhouda Ouerradi1, Ghannam Ayad1, Aziza Elouali1
1Pediatrics and Child Health, Mohammed VIth University Hospital, Mohammed 1st University Faculty of Medicine and Pharmacy of Oujda, Oujda, MAR.
Cureus
|September 30, 2024
概括
遗传性第七因子 (FVII) 缺乏症是一种罕见的出血障碍. 及时诊断和量身定制的治疗,包括复合激活FVII (rFVIIa),对于有效管理儿科病例至关重要.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 遗传性第七因子 (FVII) 缺乏症是一种罕见的自体相衰退性出血障碍.
- 对于启动凝血级联,FVII是必不可少的.
- 临床表现和FVII缺乏症的严重程度差异很大.
研究的目的:
- 描述两个先天性第七因子缺乏症的儿科病例.
- 为了强调准确的静血评估的重要性.
- 突出针对FVII缺陷的量身定制的管理策略.
主要方法:
- 两名儿科患者的病例报告.
- 检查诊断方法,包括输血栓时间 (PT).
- 管理选项的评估:新鲜冷血 (FFP),前素复合物缩物 (PCC) 和复合活性FVII (rFVIIa).
主要成果:
- 案例1:一名5岁男孩患有长期PT (55%) 和FVII水平 (25.1%).
- 案例2:一名2岁男孩患有长期PT (24%) 和FVII水平 (4.6%).
- 再组合激活FVII (rFVIIa) 由于安全性和有效性,通常是首选的治疗方法.
结论:
- 遗传性VII因子缺乏症需要进行彻底的静血评估.
- 个性化管理策略对于儿科患者至关重要.
- 早期诊断和适当的治疗,特别是rFVIIa,可以改善结果.
相关概念视频
Disorders of Hemostasis
738
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
738
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Extrinsic and Intrinsic Pathways of Hemostasis
6.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.3K
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
3
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
3
Coagulation
5.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.4K


